Skip to content

Effect of obesity on effective concentration of ropivacaine for epidural labor analgesia

Effect of obesity on effective concentration of ropivacaine for epidural labor analgesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073273
Enrollment
Unknown
Registered
2023-07-05
Start date
2023-07-05
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor analgesia

Interventions

Group 0.0375%:During labor analgesia, ropivacaine was injected epidural with a concentration of 0.0375%
Group 0.075%:During labor analgesia, ropivacaine was injected epidural with a concentration of 0.075%
Group 0.1125%:During labor analgesia, ropivacaine was injected epidural with a concentration of 0.1125%
Group 0.15%:During labor analgesia, ropivacaine was injected epidural with a concentration of 0.15%
Group 0.1875%:During labor analgesia, ropivacaine was injected epidural with a concentration of 0.1875%

Sponsors

Hangzhou Women's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: singleton pregnancy; Aged 18 to 45 years; cervical dilation 3-5 cm; gestational age 37-41weeks; ASA (American Society of Anesthesiologists) physical status II;

Exclusion criteria

Exclusion criteria: 1. Contraindication of epidural anesthesia; 2. Scarred uterus; 3. severe medical or obstetric complications; 4. allergic to local anesthetics.

Design outcomes

Primary

MeasureTime frame
VAS;blood pressure;heart rate;

Countries

China

Contacts

Public ContactXiaodong Huang

Hangzhou Women's Hospital

350236963@qq.com+86 150 6879 0428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026